journal article·2023-02-09Open access

Exosomes derived from mir-214-3p overexpressing mesenchymal stem cells promote myocardial repair

Wenwu Zhu, Qingjie Wang, Jian Zhang, Ling Sun, Xiu Hong, Wei Du, Rui Duan, Jianguang Jiang, Yuan Ji, Haoran Wang, Bing Han

Biomaterials Research· Volume 27· Issue 1

Abstract

Abstract Aims Exosomes are known as nanovesicles that are naturally secreted, playing an essential role in stem-mediated cardioprotection. This study mainly focused on investigating if exosomes derived from miR-214 overexpressing mesenchymal stem cells (MSCs) show more valid cardioprotective ability in a rat model of acute myocardial infarction (AMI) and its potential mechanisms. Methods Exosomes were isolated from control MSCs (Ctrl-Exo) and miR-214 overexpressing MSCs (miR-214 OE -Exo) and then they were delivered to cardiomyocytes and endothelial cells in vitro under hypoxia and serum deprivation (H/SD) condition or in vivo in an acutely infarcted Sprague-Dawley rat heart. Regulated genes and signal pathways by miR-214 OE -Exo treatment were explored using western blot analysis and luciferase assay. Results in vitro , miR-214 OE -Exo enhanced migration, tube-like formation in endothelial cells. In addition, miR-214 OE -Exo ameliorated the survival of cardiomyocytes under H/SD. In the rat AMI model, compared to Ctrl-Exo, miR-214 OE -Exo reduced myocardial apoptosis, and therefore reduced infarct size and improved cardiac function. Besides, miR-214 OE -Exo accelerated angiogenesis in peri-infarct region. Mechanistically, we identified that exosomal miR-214-3p promoted cardiac repair via targeting PTEN and activating p-AKT signal pathway. Conclusion Exosomes derived from miR-214 overexpressing MSCs have greatly strengthened the therapeutic efficacy for treatment of AMI by promoting cardiomyocyte survival and endothelial cell function. Graphical abstract
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · Cardiac Fibrosis and Remodeling · MicroRNA in disease regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Division of Cardiology, Xuzhou Central Hospital, Xuzhou Clinical School of Nanjing Medical University, Xuzhou Institute of Cardiovascular Disease, Xuzhou, Jiangsu, China.

Department of Cardiology, the Affiliated Changzhou No. 2 People’s Hospital of Nanjing Medical University, Changzhou, Jiangsu, China.

Department of Echocardiography, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases, Shanghai Institute of Medical Imaging, Fudan University, Shanghai 200000, China.

Department of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.

Funding

the Youth medical innovation project of Xuzhou Health Commission · Science and Technology Service Network Plan · the Young Talent Development Plan of Changzhou Health Commission · the Natural Science Foundation of Jiangsu Province · the National Natural Science Foundation of China · Nanjing Universities of Chinese Medicine

References (39)

Show source-provided references
1. 10.1016/S0140-6736(19)30427-110.1016/S0140-6736(19)30427-1 ↗
2. 10.1097/HM9.000000000000000310.1097/HM9.0000000000000003 ↗
3. Galiuto L, DeMaria A, Iliceto S. Microvascular damage during myocardial ischemia-reperfusion: pathophysiology, clinical implications and potential therapeutic approach evaluated by myocardial contrast echocardiography. Italian heart journal: official journal of the Italian Federation of Cardiology. 2000;1(2):108–16. 1:STN:280:DC%2BD3c7pt1ymsQ%3D%3D
4. 10.1161/CIRCRESAHA.118.31463510.1161/CIRCRESAHA.118.314635 ↗
5. 10.1016/j.jacc.2020.02.04110.1016/j.jacc.2020.02.041 ↗
6. 10.1016/j.jacc.2016.07.73910.1016/j.jacc.2016.07.739 ↗
7. 10.1038/s41569-019-0216-z10.1038/s41569-019-0216-z ↗
8. 10.1161/CIRCULATIONAHA.118.03459810.1161/CIRCULATIONAHA.118.034598 ↗
9. 10.1038/nrcardio.2014.20710.1038/nrcardio.2014.207 ↗
10. 10.1186/s12951-021-00808-510.1186/s12951-021-00808-5 ↗
11. 10.1038/s41419-020-02783-510.1038/s41419-020-02783-5 ↗
12. 10.3389/fcell.2020.0026310.3389/fcell.2020.00263 ↗
13. 10.1615/CritRevTherDrugCarrierSyst.v29.i6.2010.1615/CritRevTherDrugCarrierSyst.v29.i6.20 ↗
14. 10.1038/s41587-020-0696-810.1038/s41587-020-0696-8 ↗
15. Hirai K Ousaka D Fukushima Y et al. Cardiosphere-derived exosomal microRNAs for myocardial repair in pediatric dilated cardiomyopathy. Science translational medicine 2020;12(573).10.1126/scitranslmed.abb3336 ↗
16. 10.1186/s12943-021-01349-z10.1186/s12943-021-01349-z ↗
17. 10.1038/s41556-019-0404-410.1038/s41556-019-0404-4 ↗
18. 10.1097/HM9.000000000000003910.1097/HM9.0000000000000039 ↗
19. 10.1186/s13287-021-02282-010.1186/s13287-021-02282-0 ↗
20. 10.1016/j.neuroscience.2019.10.04310.1016/j.neuroscience.2019.10.043 ↗
21. 10.1016/j.biomaterials.2011.10.07810.1016/j.biomaterials.2011.10.078 ↗
22. 10.1186/s13287-020-01811-710.1186/s13287-020-01811-7 ↗
23. 10.1093/eurheartj/ehz78710.1093/eurheartj/ehz787 ↗
24. 10.1016/j.acthis.2023.15204110.1016/j.acthis.2023.152041 ↗
25. 10.1002/jcb.2463610.1002/jcb.24636 ↗
26. 10.1182/blood-2013-02-47892510.1182/blood-2013-02-478925 ↗
27. 10.18632/aging.10259210.18632/aging.102592 ↗
28. 10.1016/j.jconrel.2014.09.00110.1016/j.jconrel.2014.09.001 ↗
29. 10.1126/science.286.5448.224410.1126/science.286.5448.2244 ↗
30. 10.4330/wjc.v8.i2.16310.4330/wjc.v8.i2.163 ↗
31. 10.1016/j.ymthe.2017.03.02110.1016/j.ymthe.2017.03.021 ↗
32. 10.1038/d41573-020-00220-y10.1038/d41573-020-00220-y ↗
33. 10.1038/s41580-020-0251-y10.1038/s41580-020-0251-y ↗
34. Janas T Janas P Sapoń K Janas T. Binding of RNA aptamers to membrane lipid rafts: implications for exosomal miRNAs transfer from Cancer to Immune cells. Int J Mol Sci 2020;21(22).10.3390/ijms21228503 ↗
35. 10.1038/s41467-020-15747-210.1038/s41467-020-15747-2 ↗
36. 10.1161/CIRCRESAHA.118.31242010.1161/CIRCRESAHA.118.312420 ↗
37. 10.1172/JCI5932710.1172/JCI59327 ↗
38. 10.1536/ihj.15-29310.1536/ihj.15-293 ↗
39. 10.1155/2018/497126110.1155/2018/4971261 ↗